Becton Dickinson Total Non-Operating Income/Expense 2010-2024 | BDX

Becton Dickinson annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Becton Dickinson total non-operating income/expense for the quarter ending September 30, 2024 was $-0.108B, a 35.33% decline year-over-year.
  • Becton Dickinson total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.392B, a 12.69% decline year-over-year.
  • Becton Dickinson annual total non-operating income/expense for 2024 was $-0.393B, a 12.47% decline from 2023.
  • Becton Dickinson annual total non-operating income/expense for 2023 was $-0.449B, a 10.02% decline from 2022.
  • Becton Dickinson annual total non-operating income/expense for 2022 was $-0.499B, a 10.73% decline from 2021.
Becton Dickinson Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $-393
2023 $-449
2022 $-499
2021 $-559
2020 $-498
2019 $-584
2018 $-336
2017 $-546
2016 $-356
2015 $-335
2014 $-84
2013 $-89
2012 $-86
2011 $-48
2010 $-16
2009 $-11
Becton Dickinson Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-108
2024-06-30 $-102
2024-03-31 $-101
2023-12-31 $-81
2023-09-30 $-167
2023-06-30 $-78
2023-03-31 $-100
2022-12-31 $-104
2022-09-30 $-170
2022-06-30 $-115
2022-03-31 $-122
2021-12-31 $-92
2021-09-30 $-231
2021-06-30 $-114
2021-03-31 $-130
2020-12-31 $-84
2020-09-30 $-110
2020-06-30 $-110
2020-03-31 $-170
2019-12-31 $-108
2019-09-30 $-113
2019-06-30 $-165
2019-03-31 $-133
2018-12-31 $-173
2018-09-30 $-162
2018-06-30 $136
2018-03-31 $-180
2017-12-31 $-130
2017-09-30 $-162
2017-06-30 $-181
2017-03-31 $-84
2016-12-31 $-119
2016-09-30 $-88
2016-06-30 $-93
2016-03-31 $-90
2015-12-31 $-85
2015-09-30 $-105
2015-06-30 $-98
2015-03-31 $-68
2014-12-31 $-64
2014-09-30 $-24
2014-06-30 $-23
2014-03-31 $-18
2013-12-31 $-19
2013-09-30 $-16
2013-06-30 $-26
2013-03-31 $-21
2012-12-31 $-26
2012-09-30 $-27
2012-06-30 $-30
2012-03-31 $-14
2011-12-31 $-14
2011-09-30 $-19
2011-06-30 $-12
2011-03-31 $-12
2010-12-31 $-5
2010-09-30 $4
2010-06-30 $-10
2010-03-31 $-3
2009-12-31 $-7
2009-09-30 $-3
2009-06-30 $-3
2009-03-31 $-9
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36